|
|
BioSig Tech. (BSGM) & Electrophysiology Sector (related stock BSGM)
|
|
||
Mayo Clinic at the Heart of Healthcare With Rising Number of Innovative Collaborations (Benzinga)snip> PALM BEACH, Florida, Sept. 12, 2019 /PRNewswire/ -- When people all around the world hear the name "Mayo Clinic" that usually translates to "the best". The Mayo Clinic has worked long and hard to deserve that perception, which is entirely earned. The people that make up the Clinic may however prefer they are not 'working' but are on a mission. In a recent release on their news network, they define themselves as: "Mayo Clinic is… committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing." They are researchers, practitioners and importantly… innovators. As such Mayo has been partnering with a myriad of technology partners and collaborators that they believe will help them to take even greater strides than before. One such partnership recently announced was with Google, of Alphabet Inc. (NASDAQ:GOOG). Mayo said: "Mayo Clinic and Google announced a 10-year strategic partnership… This partnership will redefine how health care is delivered and accelerate the pace of health care innovation through digital technologies. Mayo Clinic selected Google Cloud to be the cornerstone of its digital transformation. Mayo will use advanced cloud computing, data analytics, machine learning and artificial intelligence (AI) to redefine health care delivery, bringing together global providers and consumers to make health care better." Active stocks in the healthcare industry today include: BioSig Technologies, Inc. (NASDAQ:BSGM), Alphabet Inc. (NASDAQ:GOOG), Medtronic plc (NYSE:MDT), Varian Medical Systems, Inc. (NYSE:VAR), iRhythm Technologies, Inc. (NASDAQ:IRTC). This deal with Google, however, should benefit all of Mayo's partnerships because Mayo Clinic will continue to control access and use of its patient data by using Google's cloud technologies and they will specifically authorize the use of data in projects to create new health care insights and solutions in conjunction with their partners, including Google. Google said in their release about the collaboration: " We are excited that Google Cloud will be core to Mayo Clinic's digital transformation, and we look forward to combining our world-class cloud technology and engineers with Mayo Clinic's industry-leading clinicians, researchers and innovators. Working together, we can transform healthcare and improve lives." BioSig Technologies, Inc. (NASDAQ:BSGM) BREAKING NEWS - BioSig Technologies, a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it signed a new licensing agreement with Mayo Clinic. The new agreement aims to develop a new product pipeline to support some of the more advanced features of BioSig's first product, PURE EP(tm) System. The development program will be run under the leadership of Samuel J. Asirvatham, M.D., Mayo Clinic's Vice-Chair of Innovation and Medical Director, Electrophysiology Laboratory. "We are very pleased to expand our relationship with the outstanding physician team at Mayo Clinic. Their commitment to improving patient care resonates deeply with our Company's mission to bring innovative technological solutions to medicine, and we are looking forward to this next chapter in our collaboration. The new product that we intend to develop under the latest licensing will seek to significantly advance the current arrhythmia treatments. It will be an exciting journey, and we look forward to reporting on our progress," commented Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. Earlier this year, BioSig Technologies received nearly $1 million
in financing from the Mayo Clinic after working with the healthcare
organization for two years. BioSig completed first-in-human studies at
the Rochester, Minn.-based
clinic aimed at validating the safety and efficacy of its Pure EP
system during mapping and ablation procedures in a cardiac EP lab.
Patient studies were also conducted at Texas Cardiac Arrhythmia
Institute at St. David's Medical Center and at Greenville Memorial in North Carolina, according to the Wayzata, Minn.-based company. Previously, BioSig conducted preclinical studies at Mayo. Read this and more news for BSGM at: https://www.financialnewsmedia.com/news-bsgm |
return to message board, top of board |